Rhodesian Instruments is in talks with a number of medical device makers to sell their electronic medical instruments to healthcare customers.
The news comes as the company prepares to launch its first digital medical instrument.
The company’s founder and chief executive, Dr. David Rhodis, told TechRadars audience members in a recent phone interview that the company has signed a deal with a company called OTScope Medical Instruments to sell its medical devices to the healthcare sector.
Rhods Medical Instruments has been in talks to acquire OTS, a maker of medical devices that have been on the market for decades.
Riggs Medical Instruments is currently the only company that makes the device that the FDA uses to approve new drugs.
The FDA does not approve the use of an electronic device to perform an operation.
Rigs are a class of medical equipment that use a series of electronic parts to perform various medical procedures.
The devices are generally used to deliver medications to the patient.
In addition to the devices that the drug manufacturer manufactures, the device also needs to be placed in the patient’s body, which is a process called surgery.
Risks of the new technology The risks of Riggs’ medical instruments are significant, but there are several advantages that have allowed the company to secure the deal with OTS.
First, the company says it has an extensive pipeline of new, low-cost medical devices in development.
The potential market for the medical devices could grow as a result of the potential market size of the medical device market.
The new deal will allow Riggs to bring new products to market.
Rhes products can also be used to treat cancer and other illnesses, and Riggs also has a patent on the technology.
In the medical marketplace, Riggs medical devices are increasingly used to assist patients with chronic diseases.
The device could also be a boon for the healthcare industry, because the device can provide the physician with a much faster and more effective treatment than traditional methods.
Another advantage of the deal is that it would allow the company access to a large supply of the devices.
In recent years, the medical industry has been moving away from traditional devices, including heart valves, pulmonary pacemakers, and blood pressure monitors.
The health care industry has seen a shift in the healthcare market, in part, because of advances in technology, but the companies that make the devices are also finding that the market is saturated with the devices already on the marketplace.
The move to a digital medical product has been one of the key factors that has driven the growth of the industry.
The medical market for Riggs devices has grown from a little over $10 billion in 2013 to more than $20 billion in 2016.